Understanding the significance of somatic mutations requires knowledge of the mutations that occur in vivo in healthy people. The molecular characterization of mutations in the hypoxanthine phosphoribosyltransferase (hprt) gene in 217 independent T-lymphocyte mutants from 172 donors, including smoking and non-smoking males and females, reveals a broad spectrum of in vivo somatic mutation occurring in a population of healthy people. Identification of the DNA alteration in individual mutant clones was accomplished using either one or a combination of multiplex polymerase chain reaction analysis of genomic DNA, sequencing of cDNA, and genomic DNA sequencing. The total spectrum consists of 59% (128/217) base substitutions: 126 simple and two tandem CO IT base substitutions; 39% (85/217) deletion/insertion type mutations: 30 frameshifts, 26 small (3-200 basepairs) and 27 large deletions, and two duplications; and the remaining 2% (4/217) complex mutations involving the deletion of one to 11 basepairs which are replaced by 1 to 10 basepairs. No significant difference was detected between the base substitution spectra for the smokers and the non-smokers. Analysis of the number of mutations occurring at any one base position led to the identification of three hotspots for mutations at basepairs 197, 508 and 617, in the hprt gene coding region. Spontaneous deamination of CpG may be implicated in the creation of basepair 508 as a hotspot since all mutations detected are OT transitions resulting in the nonsense mutation, TAG. At basepairs 197 and 617 both G>T transversions and G>A transitions were found indicating that at least two mechanisms were involved in creating mutations at these positions. Comparison of the mutation spectra from two populations can provide insight into the origin of the mutations. This study provides an excellent base for comparison of mutation spectra in other human populations.
Introduction
The hypoxanthine phosphoribosyltransferase (hprt) gene has been central to many studies of both the frequency and specific molecular nature of mutations, particularly somatic mutation.
•Abbreviations: FBS, fetal bovine serum; DMSO, dimethylsulfoxide; PBS, phosphate buffered saline; SDS, sodium dodecyl sulfate; OD, optical density; DTT, dithiothreitol; PCR, polymerase chain reactions; APRT, adenosine phosphoribosyltransferase; mPCR, multiplex PCR; ENU, ethylnitrosourea; BPDE, 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
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Recently it has been used as a reporter gene for evaluating the effect of exposures in human populations (1, 2) . Somatic mutation can be readily studied in human peripheral blood T-lymphocytes. The hprt gene codes for an enzyme in the purine salvage pathway and, being located on the X chromosome, the gene is hemizygous in males and functionally hemizygous in females. While a germline mutation in the gene may lead to Lesch-Nyhan syndrome or gouty arthritis in the affected individual, somatic mutations at the hprt locus are compatible with continued survival of the mutant cell. Mutant cells lacking an active enzyme can be selected in cell culture with 6-thioguanine, whose conversion to nucleotide and incorporation into the DNA is lethal to non-mutant cells with functional hprt enzyme. Individual mutant T-lymphocyte clones may be expanded for the molecular characterization of their mutations.
A large body of knowledge about the in vivo mutation spectrum of deletions, rearrangements and mutations involving restriction enzyme cutting sites has been accumulated by Southern blot analysis (3) . At birth, mutant frequencies are found on average to be low and the mutation spectrum is predominantly large structural alterations (~85%) (4) (5) (6) . The most prevalent alteration in newborns is due to deletion mutations mediated by V(D)J recombinase acting on sequences within the hprt gene which resemble the V(D)J recombinase signal sequences (7). As people age, mutant frequencies increase (8) and the proportion of large structural rearrangements in the spectrum decreases, presumably due to the accumulation over time of endogenous and induced mutations that are not gross alterations. Analysis of large numbers of mutant cells from a small number of people has shown that large structural rearrangements make up ~15% of the mutant spectrum in adults (3, 9) .
There has been much less extensive study of base substitutions, small deletions, and rearrangements of the hprt gene not detectable by Southern analysis, that occur in vivo in people. Sequence specific information on the hprt mutation spectrum has been gathered from many in vivo and in vitro studies, published and unpublished, into a database (10) . An assessment of database information shows that the hprt locus has the ability to report mutations from many mechanisms of formation and from many exposures (11). Large sets of mutants from an individual, healthy, unexposed person have not yet been analyzed for sequence specific information as would be needed to characterize an individual's mutation spectrum in relation to his or her mutant frequency. However, the mutation spectra that occur at the hprt locus in a number of small populations have been determined by studies of mutants from multiple people. These in vivo spectra will contain both mutations with endogenous origins and mutations induced by the common exposures in the populations.
Using mutant frequencies and mutation spectra to compare human populations has been discussed as a system for biomonitoring (12, 13) . If an exposed population is to be character-ized by its mutation spectrum, it is necessary to understand the nature of the 'background' mutation spectrum. The purpose of this study was to define the 'background' mutation spectrum of a healthy adult human population, including both smoking and non-smoking males and females. Mutant frequency has been determined to increase with age and years of smoking in this population (14) . In an earlier publication (15) the first 63 independent mutations characterized in this population were described. To complete the population study, an additional 154 mutations have been defined. The resulting mutation spectrum is presented here with an emphasis on the base substitutions. This spectrum is described in terms of issues important in the evaluation of a mutation spectrum and of possible mechanisms involved in producing the mutations.
Materials and methods
Peripheral blood samples of 15-20 ml per donor were obtained from a population of healthy adults. The recruitment of subjects and obtaining of samples were reviewed by institutional review boards of both Lawrence Livermore National Laboratory (LLNL) and the National Institute of Environmental Health Sceience, and all subjects gave informed consent prior to participation in this study. With the exception of three non-smoking subjects drawn from the LLNL biomedical research community, all subjects were recruited from the general public in the Raleigh-Durham area of North Carolina (14) . The selection of subjects was based on self-reporting of no recent illness; no exposure to radiation or chemicals other than smoking or over-the-counter medications; no prior history of heart disease, diabetes, tuberculosis, high blood pressure, cancer or hepatitis; and age between 19 and 62 years. Non-smokers reported no passive cigarette/cigar/marijuana smoke at home and never having smoked regularly. Smokers reported their average daily cigarette consumption for the past 3 months as a minimum of 20 cigarettes/day and having smoked for at least the last 5 years. Heparinized blood samples were shipped from North Carolina by air express and usually processed within 30 h of being drawn.
Isolation of thioguanine resistant mutants
The frequency of thioguanine resistant mutants was determined by limiting dilution using the hprt T-lymphocyte clonal assay (16, 17) . Mononuclear cells were isolated from blood samples using Lymphocyte Separation Medium (Organon Teknika-Cappel, Durham, NC). The isolated cells were either cultured immediately or viably frozen for later culturing Cells were cultured for up to 40 h at IX10 6 cells per ml with the mitogen phytohemagglutinin (PHA, 1 Ug/ml; HA 17, Burroughs Welcome), then counted and plated in round-bottomed microtiter wells with 10% (v/v) lymphokine activated killer cell (LAK) supernatant (containing 15 000 U/ml human interleukin-2, serum free medium and any factors produced during the 3-4 day activation of peripheral blood monocytes), reduced PHA (0.1 ug/ml), irradiated lymphoblastoid feeder cells (20 000 viable irradiated TK-6 per well; 50 Gy Cesium-137 delivered at 4.2 Gy per min), pVmercapto-ethanol (50 mM), with or without thioguanine (1 Ug/ml) selection. Throughout this work the basal medium was RPMI 1640 supplemented with 5% fetal bovine serum, 20% HL-1 (Hycor Biomedical Inc.), penicillin (50 U/ml) and streptomycin (50 ug/ml). All cultures were incubated at 37°C at 5% CO 2 
Determination of the frequency of mutant cells
Plates were scored for growth in individual wells using an inverted microscope on two dates, usually first after 12-15 days and again 1 week later. Donors' cells were usually plated at both one and two cells/well in the absence of thioguanine (96 wells for each density) to determine the non-selective cloning efficiency (CE); and at 1 X 10 4 cells/well in 96 wells and at 2X10 4 cells/well in up to 1144 wells in the presence of thioguanine to determine the cloning efficiency in the presence of thioguanine (ME). The hprt mutant frequency (MF) is calculated based on data from the two conditions: plates prepared in the absence of thioguanine that yield estimates of CE, and plates prepared with thioguanine that yield estimates of the ME. Mutant frequency is the ratio of ME to CE. Discussion of the statistical analysis of the MF in the donor population has previously been presented in more detail (14).
Characterization of mutations
Individual thioguanine resistant clones were expanded to 5-40X10* cells in LAK supernatant supplemented medium with PHA at 0.1 |ig/ml, by transfer to successively larger numbers of wells, or larger wells, in the presence of lethaJly irradiated lymphoblastoid cells (either TK6 or a derivative thereof, 91-XC-4, which is missing all X-linked hprt sequences). Thioguanine (1 Ug/ml) was refreshed once at the first stage of clone expansion after plating in microtiter wells. Expanded clones were frozen in 8% dimethylsulfoxide (DMSO), 20% fetal bovine serum (FBS), and 72% (RPMI) using a controlled freezing program (Cryomed) and stored in liquid nitrogen for molecular characterization.
Preparation of RNA RNA extracts were prepared from aliquots of frozen cells. 5-10X10 6 cells were thawed, rinsed once in RPMI 1640 medium with 15% fetal bovine serum, followed by two washes with cold phosphate buffered saline (PBS).
During the course of the study, three different methods of RNA preparation for reverse transcription were used. In the initial method, the washed cells were resuspended in 250 nl cold lysis buffer (10 mM Tris-HCl pH 7.8, 150 mM NaCl) containing 10 |il RNase Block II RNase inhibitor (Stratagene) per 250 ul buffer. Then, 2% Nonidet P^0 (25 ul per 250 |il lysis suspension) was added, sample vortexed and held on ice for 5 min to lyse cells. The nuclei were pelleted by centrifugation at 4°C. The supernatant containing cellular RNA was transferred to clean tubes and 250 ul extraction buffer (40 mM Tris-HCl, pH 7.8, 40 mM EDTA, 0 7 M NaCl, and 2% sodium dodecyl sulfate [SDS]) were added. The suspension was extracted five times with phenol:chloroform:isoamyl alcohol (25:24:1), then once with chlorofornrisoamyl alcohol (24:1). RNA was precipitated with two volumes of cold 100% ethanol. Samples were stored at -20°C. RNA was recovered by centnfugation, washed twice with a (3:1) solution of ethanol:0.1 M sodium acetate, pH 5.2. RNA pellets were dried and resuspended in diethylpyrocarbonate treated deionized H2O. RNA concentrations were determined by optical density (OD) readings. RNase Block II was added and the RNA samples were stored at -20°C or -80°C.
The other two methods used commercially available kits for isolating mRNA from small numbers of cells: Invitrogen's Micro-Fast Track mRNA Isolation Kit (K152O-O2, Invitrogen), or Pharmacia's QuickPrep Micro mRNA Purification Kit (27-9255-01, Pharmacia).
Preparation of genomic DNA
The nuclear pellets from the first method of RNA preparation were suspended in 750 ul lysis buffer (10 mM Tris pH 8, 0.4 M NaCl, and 2 mM EDTA), 125 )il proteinase K digestion solution (1% SDS, 2 mM EDTA and 250 ug Proteinase K), and 50 ul of 10% SDS. The pellets were incubated at 6O-65°C for 24-72 h. Protein and SDS were removed using salt extraction by the addition of 750 ul deionized H 2 O and 750 (J.1 of saturated (6 M) NaCl. After vigorous mixing for 30 s, the precipitated SDS and proteins were removed by two successive centrifugations. The DNA was recovered by ethanol precipitation with two volumes of cold 100% ethanol and incubation at 4°C. Precipitated DNA was rinsed twice with cold 70% ethanol. Pellets were air dried and resuspended in TE (10 mM Tris pH 8.0 and 0.1 mM EDTA). DNA concentrations were determined by OD readings.
For clones whose mRNA was prepared using kits, genomic DNA was prepared as above from whole cells.
Synthesis and analysis ofcDNA cDNA was synthesized by a modification of the SUPERSCRIPT™ 1, (or II), RNase H" reverse transcnptase reaction (RT Rx) procedure (Gibco Brl, Life Technologies, Inc.) using 2 (ig of cytoplasmic RNA per 20 ul reaction. RNA, 0.2 ug oligo d(T)| 8 and 0.5 ul RNase Block II were mixed in a total volume of 10.5 |il, heated for 2 min at 95°C, held at 45°C while adding 7.5 ul reaction mix (4 ul 5XSUPERSCRIPT™ reaction buffer, 2 ill of 0.1 M dithiothreitol (DTT), 1 ul of (dNTP) mix containing 25 uM each of dNTP, and 0.5 ul RNase Block II) and then adding 2 ul of 200 U/ul SUPERSCRIPT™ I, (or II) RNase H", Reverse Transcriptase. Samples were incubated at 45°C for 1 h, then heated to 9O-95°C for 10 mm prior to incubating 20 min at 37°C with 2U RNase H (Gibco Brl) and storage at -20°C. In some analyses the RNase H step was omitted with no consequence.
Second strand cDNA synthesis and cDNA amplification by the Taq DNA polymerase (AmpWTaq; Perkin Elmer Cetus) were carried out using the hprt specific primers previously described (15, (18) (19) (20) , in two successive polymerase chain reactions (PCR) using a PeTkin-Elmer DNA Thermal Cycler.
In some analyses, the first PCR amplifications used three different pairs of primers in separate reactions: no. 1) 250 nM each of IRJ040 and IRJ041 amplified a partial adenosine phosphoribosyltransferase (APRT) cDNA, as positive control for RNA quality: no. 2) 62 nM each of BRIN006 and IRJ048 amplified a 620 bp hprt cDNA, approximately 2/3 of the hprt cDNA from bp 140 through the 3' end; and no. 3) 62 nM each of IRJ05O and IRJ04S amplified the full length hprt cDNA. In other analyses, only primer reactions nos 1 and 3 were run. The amplification reactions (50 mM KC1. 10 mM TrisHCl, pH 8.3, 1.5 mM MgCI 2 , 150 uM each of dNTP, 2 ul of the RT Rx, and one pair of primers) were covered with mineral oil, heated at 95°C for 5 min, and held at 85°C during the addition and mixing of 1.25 U of Taq DNA polymerase into the reaction (total volume of 50 ul). A total of 35 cycles of cDNA amplification consisted of one cycle of 3 min denaturation at 93°C, 2 min primer annealing at 55°C, and 3 min elongation at 72°C followed by 24 cycles of 2 min denaturation at 93°C, 1 min primer annealing at 55°C, and 3 min elongation at 72°C, and then 10 cycles having the elongation step altered by the addition of 18 s per round. Resulting products were visualized on an agarose gel (2.5% Nusieve plus 1% Seakem agarose [FMC] in 1 XTBE) stained with ethidium bromide.
In the second PCR amplification: l/50th of the full length reaction no. 3 was used as template and the primers (15) were nested with respect to the first PCR pnmers in a 100 |il reaction (50 mM KC1, 10 mM Tris-HCl pH 8.3, 1.5 mM MgCl 2 , 200 nM of each dNTP, 0.25 nM each of IRJ046 and IRJ049, and 2 U of Taq DNA polymerase). The number of amplification cycles was based on the yield of the first PCR: 35 cycles if a full length cDNA product was not visible; 20-25 cycles if it was visible. Cycle 1 consisted of 4 min denaturation at 93°C, 2 min primer annealing at 55°C, and 3 min elongation at 72°C. Cycles (N-l) were 2 min denaturation at 93°C, 1 min primer annealing at 55°C, and 3 min elongation at 72°C. The last 10 cycles had the elongation step altered as above. Products were evaluated by agarose gel electrophoresis.
The hprt cDNA PCR products were agarose gel purified using GeneClean (BIO 101, Inc.) and quantified by comparison of the cDNA template to DNA size markers on agarose gels stained with ethidium bromide.
Analysis of genomic DNA Individual exons and flanking intron sequences were simultaneously amplified from genomic DNA (gDNA) by multiplex PCR (mPCR) (21) . Products were analyzed on 1.4% Seakem agarose gels stained with ethidium bromide. Individual exon bands were excised from the gel, minced in sterile deionized H 2 O, and refrigerated overnight. AJiquots of the eluted cDNA were used as template for PCR to amplify exon-specific fragments and introduce the M13 'universal' priming sequence for sequencing the product (21) . PCR products were prepared for sequencing by one or a combination of several methods: (1) ethanol precipitation; (2) Microcon-100 filtration by centrifugation (Amicon, Inc); and (3) agarose gel purification and recovery of the specific product using GeneClean (BIO 101, Inc) The template DNA was quantified on agarose gels prior to sequencing. The DNA template integrity was confirmed using non-hprt primers for mutants for which no mPCR product was amplified.
Sequencing
Four fluorescent primers were used for sequencing hprt cDNA (15) . IRJ051 and IRJ054 were used first; IRJ052 and IRJ053 were used when necessary to clarify results. Dideoxy sequencing reactions utilized a modification of the Applied Biosystems Inc. (ABI) Taq polymerase based cycle sequencing protocol. Individual base reactions were performed with larger volumes: 14 (il for A and C, each with 16.8 ng template, and 28 |il for T and G, each with 33.6 ng template. Dideoxy/deoxy nucleotide mixtures did not use modified bases. Cycling times and temperatures were: 10 cycles of denaturation at 93°C for 2 min, annealing at 55°C for 1 min and elongation at 72°C for 2 min; followed by 15 cycles of denaturation at 93°C for 30 s and elongation at 70°C for 1 rain.
Sequencing reaction products of cDNA and gDNA templates were analyzed using the ABI 373A DNA Sequencer. Sequence data were compared to wild type sequence using ABI SeqEd™ 675: DNA Sequence Editor.
Mutation spectrum analysis
Mutation spectra comparisons utilized the spectra comparison algorithm developed by Adams and Skopek (22) as presented by Cariello in the mutation spectra comparison routine in his database analysis programs (10) . The algorithm provides a Monte Carlo estimation of the P value generated by the hygergeometric test which is a generalization of Fisher's exact test (twotailed) for tables with more than two rows and columns (22) . Cariello's analysis examines only single base substitutions in the hprt coding region. In spectral comparisons the program assumes that two spectra are the same and then tests this assumption. The routine calculates a P value based on the position and nature of the mutations. A P value of *0.05 indicates that the spectra are not the same at the 95% confidence limit.
Statistical analysis of the base substitution mutation spectrum was accomplished by entering the data from Table IV into Release 3 of the Cariello hprt mutation database. Subsets of the data in Table IV were defined, such as smokers and non-smokers, and used to create working databases for statistical comparisons by the database analysis programs. The comparison of two spectra takes into account the base position of each mutation, the quantity of each change and the specific base substitution of each mutation in deciding if two spectra are the same or different.
In addition, the Cariello database facilitated comparisons with data from other studies. From the Release 3 database, subsets of base substitution data that resulted from particular exposures in specific cell types and of data from gout and Lesch-Nyhan syndrome were defined. These subsets provided the various base substitution mutation spectra that were used for the comparisons with the base substitution data from Table IV. Hotspots for mutation were defined by determining the maximum number of mutations that one would expect to see at any site, given the total number of mutations identified in this study and the number of mutable sites that have been reported in the hprt gene (10); and then looking for sites that exceeded that number by a wide margin. The exact tail distribution for the maximum of a multinomial random variable was calculated using S-PLUS (23) by the method described by Levin (24) . The required convolutions of truncated Poisson random variables were calculated using a finite Fourier transform. The order-of-magnirude of the tail probabilities for large values of k were validated using Bonferroni inequalities (25) .
Results
The hprt T-lymphocyte clonal assay was used to measure the frequency of mutant cells that occur in vivo in the peripheral blood lymphocytes of an individual and to recover clones of mutant cells. The T-lymphocyte mutant clones analyzed in this study were taken from the large number of thioguanineresistant mutant clones recovered by thioguanine selection in the mutant frequency determination. The mutations presented here are somatic mutation events that occurred in vivo in the individual donors. Thioguanine selection was imposed within 40 h of initiation of cell culture, making formation and selection of new mutations in the laboratory highly unlikely. For most donors, only one mutant clone per donor was analyzed. This experimental design ensured the independence of the mutations and resulted in a mutation spectrum reflective of the large population of healthy people. For 50 donors, 26 smoking donors with high (> 11X10^) mutant frequencies and 24 nonsmoking donors with low (<11X1O~6) mutant frequencies, a second clone was analyzed to increase likelihood of distinguishing specific smoking related mutations. When two mutant clones from one donor were analyzed, only clones with different changes were included in the mutation spectrum, ensuring the independent origin of all mutations reported. A total of 251 mutant clones from 194 donors was analyzed. A summary of the donor population studied and the frequency of thioguanine resistant mutants in the population is presented in Table I . The healthy donor population consisted of both male and female smokers and non-smokers. More smoker than non-smoker mutations, and more male than female mutant clones, were characterized. No difference was seen in spectra comparisons by gender. However, the numbers of mutations in the gender comparisons are small and may not provide for a meaningful analysis.
The strategy for the identification of the molecular nature of the individual mutation leading to the thioguanine resistant mutant phenotype was based on the analysis of both cDNA and genomic DNA of the hprt gene in each mutant clone. A combination of three different approaches was performed for each mutant. On the gross genomic DNA level, the presence or absence of the total or part of the gene sequence was determined by screening with the polymerase chain reaction for the presence or absence of the individual exons or an alteration of the size of the individual exons as an indication of insertion and deletion mutation. In mutants having intact exonic sequences, the total coding region was sequenced making use of hprt mRNA from the clone to produce cDNA. When a mutation was not found in the cDNA, the mutant clones from females presented analysis problems due to the presence of both wild type and mutant genomic DNA; hence fewer mutants from females were studied. If mRNA was absent or not available from a mutant clone, the individual exons and flanking intron exon splice sites from genomic DNA were sequenced. In cases where cDNA sequence indicated aberrant mRNA splicing, the genomic DNA of the affected exon and flanking splice sites was sequenced.
A concerted effort was made to define at the genomic DNA level mutations that affect mRNA splicing in order to assess their impact on and avoid bias in the mutation spectrum. The analysis of cDNAs identified 62 mutants with aberrant splicing of their mRNA resulting in either skipped exons or the inclusion of intron sequences between consecutive exons. The mRNA splicing signal consensus sequences must be considered part of the target for gene inactivation: 32 mutants were found to have base substitutions in an exon splice site. Seven new mutation positions in splice sites were found. Table II shows the outcome of the analyses performed on genomic DNA from these mutants. These results emphasize the importance of defining the cause of deleted exons in the cDNA by analysis of genomic DNA and demonstrate that a variety of events can cause aberrant splicing of mRNA. An explanation at the DNA level for the thioguanine resistance in 34 of the 251 mutant clones was not obtained. Of these 34, 18 mutants either had no change from the wild type sequence in the coding region of their cDNA; or in the case of cDNA exon skips, had no genomic DNA change in the intron splice sites or within the skipped exon. Presumably, these mutants contain mutations affecting splicing signals embedded in introns, the promoter functions, and other sequences related to gene expression, such as polyadenylation, or other important areas outside the gene specific coding region that are not yet defined or functionally understood. The remaining 16 mutants, many of them from females, showed exon skips in their cDNA, but the underlying change in the genomic DNA was not analyzed.
In addition to these results, four instances of possible mutant lymphocyte clonality were identified. The second clone analyzed for three of the 50 donors had the same mutation as the first clone, indicating possible clonality in the donor's mutant population though the mutant frequencies (MF) were within the normal variability seen between individuals (MF = 4.4, 12.4, and 22.4X10" 6 ). This incidence of clonality (8%) found by sequence analysis is similar to the 10% seen by Southern blot analysis of T-cell receptors (3). In another donor, one out of the total 194 donors, mutation analysis showed strong molecular evidence for clonality of prethymic stem cells as the basis for his exceptionally high mutant frequency (361X10" 6 ) (26). The repeat mutations from these four individuals were excluded from the data. This exclusion should have little effect on the mutation spectrum.
A final total of 217 DNA changes in mutants of independent origin from 172 donors have been characterized. Table III summarizes the mutation spectrum of the human population being studied. Simple base substitution mutations were the most common mutation observed constituting 58% (126/217) of the mutation spectrum. One percent (2/217) were tandem base substitutions (COTT). Deletion and insertion mutations represented 39% (85/217) of the total spectrum. In addition, 2% (4/217) of the spectrum represented complex mutations involving the deletion of 1-11 basepairs that were replaced by 1-10 basepairs. Details about the deletion and insertion mutations will be published separately (27; unpublished data). The base substitution portion of the mutation spectrum is presented and discussed below.
All the base substitution data are compiled and summarized in Tables IV through VMI and Figure 1 . The simple and tandem base substitution mutation results are presented in Table IV , arranged according to their position in the cDNA. For 122 of the 128 base substitution mutants, either the total cDNA or all the exons in the genomic DNA were sequenced. Only in six of 128 mutants was the sequence analysis stopped after finding a base substitution mutation in the genomic DNA. Of these six mutants: two had only one exon sequenced, two had four exons sequenced, one had six exons and one had eight exons sequenced.
The mutation spectrum considers both the position and the relative frequency of different base substitution mutations in the population. Figure 1A , B and C graphically presents the base substitution mutation spectrum. Analysis of the number of mutations occurring at any one base position led to the identification of three positions exhibiting a significantly (44) 14 (15) 11 (12) 16 (17) (0) 100 (109) female % (no.) 67 (18) 67 (18) (0) (0) 33 (9) 18 (5) 15 (4) (0) (0) 100 (27) 59 (128) 58 (126) 1 (2) 2 (4) 39 (85) 14 (30) 12 (26) 12 (27) 1 (2) 100(217) The complex mutations involved a replacement of 1-11 basepairs with 1-10 basepairs of unknown origin.
greater number of mutations than others indicating these three positions maybe 'hotspots' for mutation. In this spectrum, five or more mutations at any one base position was significant (P = 0.013). Twenty-two mutations representing 23% of the base substitution mutations in the coding region were recovered at the three hotspot positions: basepairs 197, 508 and 617. These hotspots have occurred in the absence of any known major exogenous exposure.
The base substitution mutation spectrum was analyzed from a variety of perspectives. Table V summarizes the simple base substitution mutations in the coding region (75%) and exon splicing consensus sequences (25%). Mutations in these regions would alter the putative hprt protein product. Mutations within the coding region are distributed among nonsense mutations, which prematurely terminate the protein (14%), mis-sense mutations producing amino acid substitutions (58%), and mutations at two base positions of the protein translation initiation codon (3%). Table VI provides a summary of the specific base substitutions identified as transitions and transversions. Table VII gives the proportions of transitions and transversion mutations at AT and GC basepairs, separately for non-smokers and smokers. Table VHI lists 13 positions, 10 in the coding region and three in flanking splice site sequences, at which different base substitutions have been seen. Different bases substituted at a position may be indicative of the action of more than one mechanism in producing the mutations at these 13 positions. Two of the three hotspots, 197 and 617, are among these 13 positions, while at hotspot position 508 only one type of base change was seen.
In characterizing the mutation spectrum of this population, it was found that the base substitution mutation spectrum at the hprt gene had not yet been completely defined. Four new mutable sites were found in this study, in addition to the 230 mutable positions previously reported out of 657 bases in the coding region (10). Also, 14 new different base substitutions were found at 14 positions, including introns, at which other base substitutions have been found by others. These new mutations are annotated in Table IV . Mutations were seen at 24% (57 sites) of the total hprt 234 mutable sites in the coding region.
Discussion
This study of 'background' mutation spectrum, using hprt as a reporter gene, provides insight into issues of somatic mutation analysis that may be applicable to genes critical for cancer progression and human disease. The study has assessed the nature of in vivo somatic mutation in a population of healthy people. It represents the largest study of independent, in vivo, somatic mutations at the hprt gene of lymphocytes from a healthy unexposed human population and defines a background mutation spectrum at the DNA sequence level. Since point mutations potentially give the most detailed information about the specificity and mechanisms involved in mutagenesis for such a population, this discussion focuses on the base substitution mutation spectrum. It is, however, important to keep in mind that base substitutions constitute only 59% of the population's mutation spectrum. The other 41 % of the spectrum is equally divided among frameshift mutations of ± 1 or 2 bps, small and large deletions in addition to a few complex mutations. This insertion/deletion portion of the spectrum has potential for the comparison of different populations, particularly those with radiation exposure (27) . Detailed data of the deletion/insertion portion of the mutation spectrum will be published separately.
The diversity of the mutation spectrum promotes an appreciation for the wide range of events occurring that may result in a mutation in the DNA of a cell. The mutation spectrum is composed of mutation subsets that represent different causal events. Among these are both endogenous events: spontaneous deamination, polymerase errors, metabolism, individual DNA repair competence and capacity; and exogenous environmental factors: food, water, air, medical X-rays, life-style choices and occupational exposures, etc. It is the combination of the specific damage to the DNA and the mechanisms by which the cell processes damage that produced the mutations defined in this study.
The human hprt gene shows extensive mutability in terms of both the number of sites and types of mutations recoverable by in vitro selection for inactivation of the gene product by selection for resistance to thioguanine. Study of the crystal structure of the hprt encoded protein has illustrated that mutations affecting the function of the enzyme are distributed throughout the structure (28) . Mis-sense mutations resulting in the absence of enzyme activity have been found to occur predominantly in conserved amino acids (29) . The total spectrum of base substitution mutations observed at the hprt locus includes 'background' mutations recovered in vitro from control cells, mutations from cells exposed in vitro to model 35A6  16B3  20B2  58C10  25H11  77B5  49A1  7G11  15B1  15B4  65A5  7E5  69H10  86F4  75 E7  84F4  4G3  4B10  79F3  43A8  44 E6  17C6  74E10  6D6  17H8  68B12  33A10  55B10  4C1  6H4  24 E7  48F2  15A2  59BD7  26H7  58F9  74C12  49H1  14B6  24A10  17G12  66F6  33G8  14 El  37D1  44B10  96A10  55B7  66D7  58H12  38B6  5A5  44B4  5H5  77G11  34F5  16G9  27C1  39B10  28G2  68B10  65B/C12  59G4  59F3  9H9  55G2  18F6  38H1  54A2 1  1  1  1  2  2  2  2  2  2  2  2  2  2  2  2  2  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  3  4  4  4 Base 1 is the A of the protein synthesis initiation codon in non-transcribed strand of the hprt cDNA. Nomenclature for intron bases is as used in (53), e.g. E8:-5 refers to the fifth base upstream of exon 8 within intron 7. compounds, and mutations arising in vivo in cells from various human populations. The considerable overlap between the mutable sites observed in vivo and in vitro indicates that the same sites are targets for damage, and that the mechanisms producing mutations are similar, in instances of 'background' and exposure induced mutation. Damage from a mutagenic exposure must produce a large and specific signal to be detected over the background mutation spectrum as a consequence of the broad spectrum of mutations at the hprt gene that produce thioguanine resistance. Since cigarette smoking did increase the lymphocyte hprt mutant frequency of the population significantly, a subset of mutations in the smoker population is expected to have been induced by cigarette smoke (14) . However, the analysis of lymphocyte hprt mutation spectra in this study revealed that the mutation 1878 spectrum of this group of smokers can not be distinguished from the spectrum of the non-smokers (P = 0.2). This implies that cigarette smoke causes the same base substitution mutations in lymphocytes as are caused by the 'background' exposures and endogenous events represented in the spectrum of the non-smokers. A smaller study of 21 non-smoker and 20 smoker base substitution mutants from 12 non-smokers and nine smokers, had a similar conclusion (30) .
While there is a trend towards more transitions in the nonsmokers and towards more transversions in the smokers, with the numbers of base substitution events found in the current study the difference is not significant (P = 0.1, coding region only; P = 0.4, including intron base substitutions). Spectra having a higher proportion of transitions have been attributed to intrinsic polymerase errors (31) . In the pooled smoker and 
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non-smoker mutations, more transitions and transversions occurred at GC basepairs than at AT basepairs despite the fact that there are 1.4 times more AT basepairs that can produce an amino acid change when mutated (2). This bias for mutation at GC basepairs indicates that there is more damage at these sites and/or a lack of proper repair of the damage.
The amount and diversity of the DNA damage caused by exposure to the complex mixture of mutagens in cigarette smoke may have contributed to the absence of a clear smoking effect on the lymphocyte hprt mutation spectrum in this population. Lymphocytes receive a lower and perhaps different exposure to the individual mutagenic components and metabolites of cigarette smoke, as compared with directly exposed cells of the respiratory tract. There is evidence that dose can influence the mutation spectrum recovered in vitro, with high cytotoxic doses producing a different spectrum than low noncytotoxic doses in hamster V-79 cells (32) . Cigarette smoking produces a relatively low dose, chronic exposure of lymphocytes, which might result in a broad mutation spectrum in the same way that the background spectrum is broad from the low level lifetime exposures. Also, there may be variability between individual smoker's responses to smoke and susceptibilities to DNA mutation.
Mutation spectra may be utilized to examine mechanisms of mutation. There is indication that multiple mechanisms of mutation were active at certain base positions, producing two or three different base substitutions at the same position. The substitutions could reflect damage from different compounds causing different types of adducts at a base, or possibly, as investigated by Rodriguez and Loechler, from multiple configurations in the DNA of the same adduct (33) . The specific base substitutions detected in this study reflect multiple mechanisms for mutation formation from both endogenous and exogenous events. The large number of G>A transitions could be caused by depurination of an adducted G, which is non-instructive for the polymerase and an A may be inserted by default. Bulky (+)-anti enantiomer of 7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE)-like adducts could be contributing to the high number of G>T transversions. The base substitutions in the spectrum also reflect the capability of the cell to deal with different adducts. The different substitutions could represent differing methods by which the cell processes the damage, as is seen with alkylating agents where one type of adduct such as O 6 ethyl guanine is rapidly repaired but O 4 ethyl thymine accumulates in the target cell population (34) . Analysis of sequence specific adduct formation and mutation formation is needed to address the issue of differential susceptibility to damage and repair in DNA sequences. Among the endogenous mechanisms of mutation, oxidative damage to DNA caused by oxygen free radicals is proposed to be a primary cause of mutation (35) and may be an important contributor to the mutation spectrum seen in this study. Oxidation of guanine produces 8-hydroxydeoxy guanine (8-O-dG) in DNA and allows the modified base to pair with adenine resulting in a G>T transversion. Alternatively, the oxidation of guanine in the nucleotide pool of a cell produces 8-O-dGTP, which can basepair with the dC or dA residues in template DNA; pairing with dA leads to an A>C transversion (36, 37) . The large number of G>T and T>G transversions in this study could reflect oxidative damage to G in the non-transcribed DNA strand and mispairing of A in the transcribed DNA strand with oxidized 8-O-dGMP, respectively. The limited number of mutation outcomes at any base position, which may be common to more than one premutagenic lesion, makes determining the exact cause of a mutation difficult. Potentially the ratio of types of mutations at a site could reveal the nature of the causative agents and mechanisms. Studies of mutations in the tumor suppressor gene p53 in skin carcinomas have shown that COTT mutations are characteristic of exposure of the skin to UV but are not found in tumors of tissues screened from UV exposure (38, 39) . Two COTT mutations were found in lymphocytes in this study, one in the transcribed strand and one in the non-transcribed strand. These tandem mutations would seem to indicate that the T-lymphocytes containing these mutations had UV exposure while circulating through sunlight exposed tissues in the body and allow one to make a connection between a human carcinogen and mutation in a background mutation spectrum. However, there is the possibility that such tandem mutations were produced by oxidative radicals as has been shown in studies using a bacteriophage (40).
DNA repair may have a role in creation of hotspots for mutation in the hprt gene. Hot spots for mutation might be cool spots for repair, as seen by Tornaletti and Pfeifer for pyrimidine dimers in p53 (41) . Poor repair of DNA lesions at specific hprt sequences in the lymphocytes of this population could explain the higher incidence of certain mutations. A review of the database for the in vitro mutation spectra induced by the model compounds ethylnitrosourea (ENU) (42) and BPDE (10,43-^7) , showed that mutations at the in vivo hotspots were not dominant and hence are not preferentially induced by them. However, it is striking that only under repair deficient conditions were mutations seen at positions 197, 508 and 617 after in vitro ENU treatment. More specifically, in repair deficient xeroderma pigmentosum cells after ENU exposure, a G>A transition was observed at both bps 197 and 617; and a OT transition at bp 508 was seen in alkyl transferase deficient ENU exposed cells (42) . The sequence context of the hotspot positions might also favor poor repair of the lesion and lead to mutation. At bp positions 197 and 617, both of which had G>A and G>T mutations, the local sequence is a TG dinucleotide repeat, (TG) 3 for bp 197 and (TG) 2 for bp 617 in the non-transcribed strand, or a CA repeat in the transcribed strand. At the 3 member CA repeat encompassing bp 197 a two basepair deletion (-CA) was detected in one mutant clone (unpublished data), adding evidence of sequence instability. Defects in mismatch repair have been shown to contribute to microsatellite instability and to produce base substitutions in addition to frameshift mutations (48) (49) (50) .
Hotspot position 508, the cytosine in a CpG site, may reflect both endogenous factors and exogenous factors. In the current study, hotspot bp 508 in five mutants has shown exclusively a OT transition leading to a nonsense mutation in the protein.
Moreover, all of the 18 mutants reported at bp 508, including 13 mutants from the Cariello database, are OT. Twelve are in vivo mutations: eight in T-lymphocyte somatic mutants (three smokers and five non-smokers) and four germinal mutations in Lesch-Nyhan patients. The OT transversion is consistent with spontaneous deamination of 5-methylcytosine to thymidine. This consistency could argue that the mutations at this hotspot are the result of an endogenous deamination event. However, the six remaining mutants were in vitro mutations recovered in studies of various mutagenic compounds: MNNG, BPDE, ENU, UV and nucleotide pool studies, where the mutation may or may not be independent of the deamination mechanism. The in vivo mutations may represent the CpG bias for OT mutations as endogenous events, whereas the in vitro mutations may reflect different mechanisms due to the adducted G.
No other CpG site dominates the mutation spectrum in this study. Although the hprt coding region contains eight CpG sites, at only five sites would base substitutions result in an amino acid change in the hprt protein and mutations have not been reported at the two relevant sites in exon 1 (10) . Failure to recover mutations at a site may be due either to the amino acid substitution not changing the enzyme activity or to the sites not being methylated and thus not biased for mutation. Mutants have been recovered for the remaining three CpG sites: bps 142, 151 and hotspot 508. Similar to bp 508, bp 151 has only OT events, including both in vivo somatic mutations and in vitro mutations after mutagenic exposures. At bp 142, both OT and OA events have occurred, indicating mechanisms other than deamination of methylated cytosine are also involved. The lack of bias for the C>T mutation at bp 142 leads to the speculation that it may not be methylated. No mutants at bp 142 and only 1 at bp 151 (OT) were recovered in this human population study and it is not known whether this low frequency is significant.
To reveal differences between mutation spectra, consistent selection criteria are required to prevent a bias imposed by the selection of mutations. The recovered mutation spectrum at a given gene is a product of all the mutations that occur being filtered through the selection criteria for detection. To compare hprt mutation spectra from different populations it is important that the mutations in the spectra are associated with the same effect on the hprt gene function. The specific damage to the DNA and the repair capacity of the cell can then be considered in understanding the mutations recovered. An example of comparing two populations with different selection criteria is the comparison of the hprt mutation spectra leading to gout and to Lesch-Nyhan syndrome. Though the spectra are significantly different (P « 0.001), this difference does not indicate that the mechanisms for the formation of the mutations are different. Rather the differing stringencies of selection (ascertainment) in the two diseases reveal different mutations in the hprt gene. The mutations in gout patients lead to a reduced level of activity of the hprt enzyme, whereas the mutations in Lesch-Nyhan leave very little or no enzyme activity. Even though the spectra are in the same gene, the comparison is not a valid reflection of causative mechanisms of mutation. This example would urge for caution in comparing tumor suppressor gene mutation spectra, where diverging spectra could be due to the selection of differences in the function of the mutated genes rather than different damage or processing of damage.
Despite the many complexities of mutation spectra, one can gain insight into the origin of mutations in two populations by comparing spectra of mutations. Because the somatic hprt mutants in the current study were isolated by thioguanine resistance based on the inactivation of the hprt enzyme, it is reasonable to compare these in vivo somatic mutations with the in vivo inherited Lesch-Nyhan mutations. It is noteworthy that the non-smoker mutation spectrum was only marginally different (P = 0.049) from the Lesch-Nyhan spectrum, whereas the smoker spectrum was highly significantly different (P < 0.001). The similarity of the Lesch-Nyhan spectrum to the non-smoker somatic spectrum could indicate that in both cases endogenous events prevail. In the smokers, perhaps the combined results of cigarette smoke along with the contemporary life exposures make their somatic mutation spectrum distinct from the Lesch-Nyhan spectrum. Another gene locus, the adenine phosphoribosyltransferase (aprt) gene, which can be studied to define mutations in somatic cells and inherited disease, shows similarity between in vivo somatic and germline mutations, perhaps reflecting endogenous events (54) . This along with the hprt in vivo spectrum illustrates appropriateness of using the in vivo somatic mutation spectrum to model events important in genetic disease. The aprt in vivo somatic mutation spectrum was found to be different from the spectrum obtained from cultured cells suggesting that the in vitro spectrum may not be able to model the events which take place in vivo (54) .
No difference was detected between the spectra from the current study and that of workers occupationally exposed to ethylene oxide (EtO). The mutation spectrum for 22 in vivo somatic mutations from workers exposed to ethylene oxide (10) was not significantly different from the smoker {P = 0.4) or the non-smoker (P = 0.6) spectra. In the absence of exposure and mutant frequency data for the workers, it is not possible to determine what proportion of the mutation spectrum might be expected to represent EtO induced mutations. Hence, the absence of a difference may not be revealing the lack of an exposure effect by EtO but may only reflect a low signal against the background mutation spectrum. However, mutations seen in the background in vivo somatic mutation spectrum were present in the mutation spectrum of 28 independent mutants after in vitro EtO exposure of normal human fibroblasts, where the increase in mutant frequencies has assured that most mutations were induced (51) .
The increasing knowledge of the specific sequence alterations that occur in mutant genes is revealing the complexity of the phenomena that determine mutation spectra and is defining the issues that must be addressed to understand the health consequences of endogenous and exogenous exposures to individuals. Whether the sequence studied is a reporter gene such as hprt or a tumor suppressor such as p53, it is necessary to understand the relationships between exposure, repair, mutation and gene function. In the future, identification of the specific adducts at specific DNA sequences may help to bridge the gap between knowledge based on single agent exposures in experimental systems and the complex mixtures that constitute normal life, e.g. metabolism, diet, lifestyle, occupational and environmental exposures. New methods, such as those of Pfeifer et al. will increase understanding of the factors that determine the position of DNA adducts (52) . Measures of exposure and knowledge of the individual susceptibility factors in metabolism and repair will also be critical.
Whereas studies of mutation spectra are essential to understand fundamental processes, mutation spectra cannot be simple biomarkers of exposure of human populations in the face of the many unknown complexities that shape them. The richness of mutation at any gene target even for single agents, the complex mixtures of life's exposures, the dependence of spectra on dose, and the undefined relationship between gene function and mutation ascertainment all confound specificity. Simple relationships between a mutation spectrum and exposure to a single agent appear to be the exception in gene inactivation, rather than the rule.
